Watch the Webinar
Berberine Deep Dive: An Update on Evidence-Based Clinical Use for Cardiometabolic Applications‡
Presented by: Kelly Heim, Ph.D.*
Berberine is an alkaloid that modifies the gut microbiome, mitochondria and cellular longevity pathways to elicit well-documented efficacy in metabolic and cardiovascular applications. Successful clinical use requires a basic comprehension of indications, dosing and pharmacological profile. Variable responses to supplementation have been partially ascribed to poor bioavailability, which can be overcome with enhanced delivery systems. In this webinar, you will learn how to use berberine effectively for the right patients and health goals.‡
- Review the clinical evidence on berberine and its effects on glucose and lipid metabolism‡
- Obtain current dosing protocols and monitoring intervals for cardiovascular and metabolic health objectives‡
- Recognize the key differences between berberine hydrochloride, sulfate and enhanced-absorption formulations
- Learn how to identify and manage potential interactions with metformin and other drugs
About the Panelist
Kelly C. Heim, Ph.D.* is Senior Scientific Director, Pharmacology & Genomics for Pure Encapsulations and Douglas Laboratories. As the co-creator of PureGenomics® and leader of its scientific advisory board, he oversees the evidence-based development of the platform and its educational resources. As a pharmacologist specializing in natural products, Dr. Heim is a published author and illustrator of various studies, scholarly reviews and book chapters. He offers complimentary learning resources on the basic and clinical pharmacology of natural products via his website, Integrative Pharmacology.
*Dr. Kelly Heim is an employee of Atrium Innovations Inc.